ELECSYS HBSAG TEST SYSTEM

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P990012 S006

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to extend application of the elecsys hbsag and elecsys anti-hbs test systems onto the updated version of the modular analytics e170 analyzer known as the cobas e 601 analyzer. While the modular analytics modular system integrates the e170 module with clinical chemistry modules p or d, the cobas e 601 immunoassay analyzer is a component of the c6000 modular system which integrates immunology testing with the cobas c 501 clinical chemistry analyser. There have been no changes to the composition of any of te test system reagents (immunoassay, controls or confirmatory test), the application parameters, the analyzer¿s analytical measuring component or how the results are calculated. The indications for use of the two test systems remain the same.

DeviceELECSYS HBSAG TEST SYSTEM
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantROCHE DIAGNOSTICS CORP.
Date Received2008-04-30
Decision Date2008-10-30
PMAP990012
SupplementS006
Product CodeLOM
Advisory CommitteeMicrobiology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address ROCHE DIAGNOSTICS CORP. 9115 Hague Road p.o. Box 50416 indianapolis, IN 46250-0457

Supplemental Filings

Supplement NumberDateSupplement Type
P990012Original Filing
S033 2018-10-26 Normal 180 Day Track No User Fee
S032 2018-04-17 Real-time Process
S031 2018-03-01 Real-time Process
S030
S029 2017-10-11 Real-time Process
S028 2017-08-03 30-day Notice
S027 2016-10-26 30-day Notice
S026 2016-02-16 30-day Notice
S025 2016-01-27 30-day Notice
S024 2016-01-27 135 Review Track For 30-day Notice
S023 2015-10-07 30-day Notice
S022 2014-11-25 30-day Notice
S021 2014-04-04 Real-time Process
S020 2013-04-09 Real-time Process
S019 2012-11-30 30-day Notice
S018 2012-10-04 30-day Notice
S017 2012-10-04 30-day Notice
S016 2012-10-03 135 Review Track For 30-day Notice
S015
S014 2012-02-29 30-day Notice
S013 2012-01-31 135 Review Track For 30-day Notice
S012 2011-10-11 Normal 180 Day Track
S011 2011-08-29 135 Review Track For 30-day Notice
S010 2011-08-17 135 Review Track For 30-day Notice
S009 2011-05-17 Normal 180 Day Track No User Fee
S008 2011-04-11 30-day Notice
S007 2008-09-02 30-day Notice
S006 2008-04-30 Normal 180 Day Track
S005 2007-09-04 Normal 180 Day Track
S004
S003 2005-10-14 Special (immediate Track)
S002 2005-08-02 135 Review Track For 30-day Notice
S001 2004-09-29 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.